Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects: A Randomized, Open-Label, Crossover Study

By Migoya Elizabeth M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 855-866

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study

By Kandhwal Kirti  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 853-863

Adis International

Access to resources Recommend Favorite

Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

By Boulton David W.  

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 619-630

Adis International

Access to resources Recommend Favorite

Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics: A Randomized, Single-Blind, Two-Period Crossover Study in Healthy Subjects

By Yin Ophelia Q.P.  

Clinical Drug Investigation, Vol. 31, Iss. 3, 2011-03 ,pp. : 169-179

Adis International

Access to resources Recommend Favorite

Bioequivalence of fixed‐dose combinations of dapagliflozin and metformin with single‐component tablets in healthy subjects and the effect of food on bioavailability

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 118-130

John Wiley & Sons Inc

Access to resources Recommend Favorite